Both Sides of the Table

APRIL 13, 2011

Brad on blogging. How did you start blogging? “My My initial desire to blog came from something that’s always been my approach to investing – I’m a nerd and I love to play with the technology and part of my approach has really been to understand things both at a user level and at a reasonably deep tentacle level. was starting.

Venture Capital 288

Venture Capital Startup Technical Review Software Review 288

Both Sides of the Table

JULY 25, 2010

I recently read a book I’d highly recommend to every reader of this blog called “ Yes, 50 Scientifically Proven Ways to be Persuasive &# by Robert B. The book is a layman’s guide to understanding how we as humans make decisions and is underpinned by data-oriented studies to prove his claims. You should, too. (no,

Guide 293

Guide Funding Venture Capital Technical Review 293

SoCal CTO

JUNE 9, 2010

Kathy Sierra at Business of Software 2009 - Business of Software Blog , May 4, 2010 "In the old days, getting customers was easy. Draw Your Ideas - A VC : Venture Capital and Technology , May 16, 2010 I saw Jack Dorsey give this talk at The 99% Conference last month. You could just outspend. Tesla is not. It's a great talk.

Startup 248

Startup Venture Capital Conference Social Media 248

Both Sides of the Table

MAY 13, 2018

I always tell founders … “An investors job is to deploy capital and make a return. For simplicity I’ll assume you’ve raised some money from angels or seed investors and you’re either raising an A round or a B round of venture capital. This goes into the heart of my controversial blog post (coming soon!

Venture Capital 332

Venture Capital Funding Startup Sales 332

Both Sides of the Table

JUNE 29, 2014

Fred Wilson wrote a Tweetstorm and then did a blog post on the topic. I never asked Marc why he stopped blogging but I presume it is some combo of having started a venture capital firm (which you might guess takes a bit of time) and also allowing some air time for his then-less-well-known compadre. To get on his radar screen.

Social Media 307

Social Media Blogging Media Startup 307

Xconomy

APRIL 20, 2018

The biggest news this week was in oncology, hands down. Merck showed that its immunotherapy pembrolizumab (Keytruda) might become a common option for many patients newly diagnosed with advanced lung cancer, but the bigger picture is that the field is moving fast.

Pricing 52

Pricing News Report Develop 52